drugset / Trial / NCT01011452

Acute Montelukast in Asthma

NCT01011452

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients presenting to hospital with an acute asthma exacerbation severe enough to require admission would receive full standard treatment according to British Thoracic Society guidelines in addition they would be offered the opportunity to take part in the study which would requite them to take a capsule of either montelukast or placebo.

Timeline

Start
2001-05
Primary completion
2004-08
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral

Indications